Modulation of plasminogen activator inhibitor-1 in vivo: a new mechanism for the anti-fibrotic effect of renin-angiotensin inhibition. [electronic resource]
Producer: 19970331Description: 164-72 p. digitalISSN:- 0085-2538
- Angiotensin II -- antagonists & inhibitors
- Angiotensin Receptor Antagonists
- Angiotensin-Converting Enzyme Inhibitors -- pharmacology
- Animals
- Antihypertensive Agents -- pharmacology
- Captopril -- pharmacology
- Cytokines -- genetics
- Enalapril -- pharmacology
- Fibrin -- metabolism
- Fibrinolysin -- metabolism
- Fibrosis
- Gene Expression Regulation, Enzymologic -- physiology
- Growth Substances -- genetics
- Imidazoles -- pharmacology
- In Situ Hybridization
- Kidney -- chemistry
- Male
- Plasminogen Activator Inhibitor 1 -- genetics
- Proteinuria -- drug therapy
- RNA, Messenger -- analysis
- Rats
- Rats, Sprague-Dawley
- Renal Circulation -- drug effects
- Renin -- antagonists & inhibitors
- Tetrazoles -- pharmacology
- Thrombosis -- drug therapy
- Tissue Plasminogen Activator -- genetics
- Urokinase-Type Plasminogen Activator -- genetics
- Vasoconstrictor Agents -- antagonists & inhibitors
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.